Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids

European Journal of Pharmacology

Volumn 340, Issue 2-3, 1997, Pages 221-225

  Dryden, Simon ^a   Burns, Simon J ^a   Frankish, Helen M ^a   Williams, Gareth ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Diabetes; Hypothalamus; Neuropeptide Y; RU486

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENERGY BALANCE; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; EATING; HORMONE ANTAGONISTS; HYPERPHAGIA; HYPOTHALAMUS; INSULIN; MALE; MIFEPRISTONE; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID;

EID: 0031565114     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01410-6     Document Type: Article

References (30)

1. Akabayashi A., Watanabe Y., Wahlestedt C., McEwan B.S., Paex X., Leibowitz S.F. Hypothalamic neuropeptide Y, its gene expression and receptor activity: Relation to circulating corticosterone in adrenalectomized rats. Brain Res. 665:1994;201-212.
2. Beck B., Jhanwar-Uniyal M., Burlet A., Chapleur-Chateau M., Leibowitz S.F., Burlet C. Rapid and localised alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res. 528:1990;245-249.
3. Bchini-Hooft Van Huijsduijnen O., Rohner-Jeanrenaud F., Jeanrenaud B. Hypothalamic neuropeptide Y messenger ribonucleic acid levels in preobese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor. J. Neuroendocrinol. 5:1993;381-386.
4. Chronwall B.M., Dimaggio D.A., Massari V.J., Pickel V.M., Ruggiero D., O'Donohue T.L. The anatomy of neuropeptide Y containing neurones in the rat brain. Neuroscience. 15:1985;1159-1181.
5. Corder R., Pralong F., Turnill D., Saudan P., Miller A.F., Gaillard R.C. Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. Life Sci. 43:1988;1879-1886.
6. Dryden S., Williams G. Leptin as a neuromodulator of feeding and energy balance. Curr. Opin. Endocrinol. Diabetes. 4:1997;124-129.
7. Dryden S., Frankish H.M., Wang Q., Williams G. Neuropeptide Y and energy balance: One way ahead for the treatment of obesity? Eur. J. Clin. Invest. 24:1994;293-308.
8. Dryden S., Pickavance L., Frankish H.M., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690:1995;185-188.
9. Frankish H.M., McCarthy H.D., Dryden S., Kilpatrick A., Williams G. Reduced neuropeptide Y receptors in the hypothalamus of the streptozocin-diabetic rat: Further evidence of increased neuropeptide Y activity. Peptides. 14:1993;941-948.
10. Frankish H.M., Dryden S., Hopkins D., Wang Q., Williams G. Neuropeptide Y, the hypothalamus and diabetes: Insights into the control of metabolism. Peptides. 16:1995;757-771.
11. Haas D.A., George S.R. Neuropeptide Y administration increases hypothalamic corticotropin-releasing factor immunoreactivity: Lack of effect in any other rat brain regions. Life Sci. 41:1987;2725-2731.
12. Hisano S., Kagotani Y., Tsuruo Y., Daikoku S., Chihara K., Whitnall M.H. Localisation of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus. Neurosci. Lett. 95:1988;13-18.
13. Langley S.C., York D.A. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am. J. Physiol. 259:1990;539-544.
14. 1-receptor mRNA levels in the arcuate nucleus of the rat. J. Neuroendocrinol. 6:1994;153-159.
15. McKibbin P.E., McCarthy H.D., Shaw P., Williams G. Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: A comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats. Peptides. 13:1991;721-727.
16. Pesonen U., Rouro J., Huupponen R., Koulo M. Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker rats. Mol. Brain Res. 10:1991;267-272.
17. Pesonen U., Koulu M., Heikinheimo O., Huupponon R. The glucocorticoid antagonists mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats. J. Endocrinol. 132:1992;425-431.
18. Sahu A., Sninsky C.A., Phelps C.P., Dube M.G., Kalra P.S., Kalra S.P. Neuropeptide Y release from the paraventricular nucleus in association with hyperphagia in streptozocin-induced diabetic rats. Endocrinology. 131:1995;2979-2985.
19. Sainsbury A., Cusin I., Rohner-Jeanrenaud F., Jeanrenaud B. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes. 46:1997;209-214.
20. Sipols A.J., Baskin D.G., Schwartz M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes. 44:1995;147-151.
21. Stanley B.G., Krykouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
22. Stanley B.G., Lanthier D., Chin A.S., Leibowitz S.F. Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: Reversal with corticosterone. Brain Res. 501:1989;32-36.
23. Stephens T.W., Basinski M., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A., MacKellar W., Rosteck P.R. Jr., Schoner B., Smith D., Tinsley F.C., Zhang X.Y., Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
24. Strack A.M., Sebastian R.J., Schwartz M.W., Dallan M.F. Glucocorticoids and insulin: Reciprocal signals for energy balance. Am. J. Physiol. 268:1995;R142-149.
25. Tempel D.L., Leibowitz S.F. Glucocorticoid receptors in PVN: Interactions with NE, neuropeptide Y, and galanin in relation to feeding. Am. J. Physiol. 265:1993;E794-800.
26. Wang Q., Bing C., Al-Barazanji K., Mossakowaska D.E., Wang X.-M., McBay D.L., Neville W.A., Taddayon M., Pickavance L., Dryden S., Thomas M.E.A., McHale M.T., Gloyer I.S., Wilson S., Buckingham R., Arch J.R.S., Trayhurn P., Williams G. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes. 46:1997;335-341.
27. White J.D., Olchovsky D., Kershaw M., Berlowitz M. Increased hypothalamic content of preproneuropeptide Y messenger RNA in streptozocin-diabetic rats. Endocrinology. 126:1990;765-772.
28. Wilding J.P.H., Gilbey S.G., Lambert P.D., Ghatei M.A., Bloom S.R. Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. Neuroendocrinology. 57:1993;581-587.
29. Williams G., Gill J.S., Lee Y.C., Cardoso H.M., Okpere B.E., Bloom S.R. Increased neuropeptide Y concentrations in the specific hypothalamic regions of the streptozocin induced diabetic rat. Diabetes. 38:1989;321-327.
30. York, D.A., 1993. Role of glucocorticoids in the development of obesity and diabetes in experimental animal models. In: Shafrir, E. (Ed.), Lessons in Animal Diabetes IV. Smith-Gordon, London, pp. 229-239.